目錄肽產品
NATR-004A
Urodilatin (95-126)
Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr (Cys11&Cys27 bridge)
Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr (Cys11&Cys27 bridge)
Size：0.5
P1(RMB)：766
MW：3506
One letter sequence：TAPRSLRRSSCFGGRMDRIGAQSGLGCNSFRY (C11&C27 bridge)
Molecular Formula：C145H234N52O44S3
Description：Urodilatin (95-126) originally extracted from human urine that corresponds to the family of natriuretic-vasorelaxant peptides found earlier in heart atria. Infusion of this peptide is found to represent a concept for the treatment of therapy-resistant acute renal failure after liver transplantion. The use of NATR-004 is protected by patents.
Literature Reference：P. Schultz-Knappe et al., Klin. Wochenschr., 66, 752 (1988)
Cas：[115966-23-9]
P1(RMB)：766
MW：3506
One letter sequence：TAPRSLRRSSCFGGRMDRIGAQSGLGCNSFRY (C11&C27 bridge)
Molecular Formula：C145H234N52O44S3
Description：Urodilatin (95-126) originally extracted from human urine that corresponds to the family of natriuretic-vasorelaxant peptides found earlier in heart atria. Infusion of this peptide is found to represent a concept for the treatment of therapy-resistant acute renal failure after liver transplantion. The use of NATR-004 is protected by patents.
Literature Reference：P. Schultz-Knappe et al., Klin. Wochenschr., 66, 752 (1988)
Cas：[115966-23-9]
-
ADD杭州市錢塘區(qū)12號大街69號
-
TEL0571-86737011
-
E-mail
Copyright ? 2024 中肽生化有限公司 All Rights Reserved.
浙ICP備05051877號-1
業(yè)務咨詢和客戶服務
企業(yè)微信公眾號
